Neomac Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 49.32%
- Profit Growth -8.88%
- Ebitda -7.58%
- Net Worth 15.43%
- Total Assets 119.71%
About Neomac Pharmaceuticals
Neomac Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 April 2015 (Nine years and nine months 22 days old ). Its registered office is in Amritsar, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sahil Mahajan, Naresh Mahajan, Mohd Mir, and One other member serve as directors at the Company.
Company Details
- Location
Amritsar, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232PB2015PTC039375
- Company No.
039375
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2015
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Neomac Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahil Mahajan  | Director | 28-Aug-2019 | Current |
| Naresh Mahajan | Director | 10-Apr-2015 | Current |
| Mohd Mir | Director | 10-Apr-2015 | Current |
| Shabir Bhat | Director | 10-Apr-2015 | Current |
Financial Performance of Neomac Pharmaceuticals.
Neomac Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 49.32% increase. The company also saw a slight decrease in profitability, with a 8.88% decrease in profit. The company's net worth Soared by an impressive increase of 15.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neomac Pharmaceuticals?
In 2022, Neomac Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ravenbhel Pharmaceuticals Private LimitedSahil Mahajan and Naresh Mahajan are mutual person
Macmillon Pharmaceuticals Private LimitedSahil Mahajan and Naresh Mahajan are mutual person
Ravenmac Pharmaceuticals Private LimitedSahil Mahajan and Naresh Mahajan are mutual person
Ravenbhel Health Care Private LimitedSahil Mahajan is a mutual person
Salutemlab Formulations Private LimitedSahil Mahajan and Naresh Mahajan are mutual person
- Salutemlife Sciences Private Limited
Sahil Mahajan and Naresh Mahajan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neomac Pharmaceuticals?
Neomac Pharmaceuticals has a workforce of 49 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neomac Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neomac Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
